October 4, 2022 October 4, 2022Categories News StoriesDREAMseq trial clarifies immunotherapy, targeted treatment order for patients with BRAF-mutant metastatic melanoma
September 30, 2022 September 30, 2022Categories News StoriesAdvanced melanoma survival improves significantly when immunotherapy is given before targeted therapy
September 28, 2022 September 28, 2022Categories News StoriesImmunotherapy before targeted therapy improves survival in advanced melanoma, according to the DREAMseq trial
September 27, 2022 September 27, 2022Categories Press ReleasesMedia Advisory: Journal of Clinical Oncology publishes outcomes from the practice-changing DREAMseq trial in patients with advanced melanoma
September 26, 2022 September 26, 2022Categories Announcements News StoriesThe Fall 2022 advocacy blog Considering Clinical Trials is now available
September 8, 2022 September 8, 2022Categories Press ReleasesPress Release: ECOG-ACRIN completes the first randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer
August 16, 2022 August 16, 2022Categories Announcements News StoriesThe August 2022 News from ECOG-ACRIN blog is now available
August 10, 2022 August 10, 2022Categories Announcements News StoriesPresident Biden announces his intent to appoint Dr. Monica Bertagnolli as the next NCI director
August 9, 2022 August 9, 2022Categories AnnouncementsEarly-career investigators: Submit an abstract for the 2022 Young Investigator Symposium by Wednesday, 9/7
